Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.
Bile acids are important endocrine signalling molecules, modulating glucose homeostasis through activation of cell surface and nuclear receptors. Bile acid metabolism is altered in type 2 diabetes mellitus; however, whether this is of pathogenic consequence is not fully established. In this study ur...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736330/?tool=EBI |
id |
doaj-c257b7fbbbf846e694c4cd20e0e45038 |
---|---|
record_format |
Article |
spelling |
doaj-c257b7fbbbf846e694c4cd20e0e450382021-03-03T20:14:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9354010.1371/journal.pone.0093540Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2.David R TaylorJamshid Alaghband-ZadehGemma F CrossSohail OmarCarel W le RouxRoyce P VincentBile acids are important endocrine signalling molecules, modulating glucose homeostasis through activation of cell surface and nuclear receptors. Bile acid metabolism is altered in type 2 diabetes mellitus; however, whether this is of pathogenic consequence is not fully established. In this study urinary bile acid excretion in individuals with type 2 diabetes and matched healthy volunteers was assessed. Urinary bile acid excretion in type 2 diabetes patients was considered in the context of prevailing glycaemia and the patient body mass index. Urine bile acids were measured by liquid chromatography-tandem mass spectrometry, allowing individual quantification of 15 bile acid species. Urinary bile acid excretion in patients with type 2 diabetes who were normal weight (BMI 18.5-24.9 kg/m2) and overweight (BMI 25-29.9 kg/m2) were elevated compared to healthy normal weight volunteers, both p<0.0001. In obese (BMI ≥ 30 kg/m2) type 2 diabetes patients, urinary bile acid excretion was significantly lower than in the normal and overweight type 2 diabetes groups (both p<0.01). Total bile acid excretion positively correlated with HbA1c in normal (rs=0.85, p=<0.001) and overweight (rs=0.61, p=0.02) but not obese type 2 diabetes patients (rs=-0.08, p=0.73). The glycaemia-associated increases in urine bile acid excretion in normal weight and overweight type 2 diabetes seen in this study may represent compensatory increases in bile acid signalling to maintain glucose homeostasis. As such alterations appear blunted by obesity; further investigation of weight-dependent effects of bile acid signalling on type 2 diabetes pathogenesis is warranted.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736330/?tool=EBI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David R Taylor Jamshid Alaghband-Zadeh Gemma F Cross Sohail Omar Carel W le Roux Royce P Vincent |
spellingShingle |
David R Taylor Jamshid Alaghband-Zadeh Gemma F Cross Sohail Omar Carel W le Roux Royce P Vincent Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. PLoS ONE |
author_facet |
David R Taylor Jamshid Alaghband-Zadeh Gemma F Cross Sohail Omar Carel W le Roux Royce P Vincent |
author_sort |
David R Taylor |
title |
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. |
title_short |
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. |
title_full |
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. |
title_fullStr |
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. |
title_full_unstemmed |
Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. |
title_sort |
urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Bile acids are important endocrine signalling molecules, modulating glucose homeostasis through activation of cell surface and nuclear receptors. Bile acid metabolism is altered in type 2 diabetes mellitus; however, whether this is of pathogenic consequence is not fully established. In this study urinary bile acid excretion in individuals with type 2 diabetes and matched healthy volunteers was assessed. Urinary bile acid excretion in type 2 diabetes patients was considered in the context of prevailing glycaemia and the patient body mass index. Urine bile acids were measured by liquid chromatography-tandem mass spectrometry, allowing individual quantification of 15 bile acid species. Urinary bile acid excretion in patients with type 2 diabetes who were normal weight (BMI 18.5-24.9 kg/m2) and overweight (BMI 25-29.9 kg/m2) were elevated compared to healthy normal weight volunteers, both p<0.0001. In obese (BMI ≥ 30 kg/m2) type 2 diabetes patients, urinary bile acid excretion was significantly lower than in the normal and overweight type 2 diabetes groups (both p<0.01). Total bile acid excretion positively correlated with HbA1c in normal (rs=0.85, p=<0.001) and overweight (rs=0.61, p=0.02) but not obese type 2 diabetes patients (rs=-0.08, p=0.73). The glycaemia-associated increases in urine bile acid excretion in normal weight and overweight type 2 diabetes seen in this study may represent compensatory increases in bile acid signalling to maintain glucose homeostasis. As such alterations appear blunted by obesity; further investigation of weight-dependent effects of bile acid signalling on type 2 diabetes pathogenesis is warranted. |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24736330/?tool=EBI |
work_keys_str_mv |
AT davidrtaylor urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2 AT jamshidalaghbandzadeh urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2 AT gemmafcross urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2 AT sohailomar urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2 AT carelwleroux urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2 AT roycepvincent urinebileacidsrelatetoglucosecontrolinpatientswithtype2diabetesmellitusandabodymassindexbelow30kgm2 |
_version_ |
1714823392555696128 |